Return On Assets of CNBX Pharmaceuticals Inc. from 28 Feb 2014 to 30 Nov 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CNBX Pharmaceuticals Inc. quarterly and annual Return On Assets in % history and change rate from 28 Feb 2014 to 30 Nov 2025.
  • CNBX Pharmaceuticals Inc. Return On Assets for the quarter ending 30 Nov 2025 was -1591%, a 115% decline year-over-year.
  • CNBX Pharmaceuticals Inc. annual Return On Assets for 2025 was -1142%, a 172% decline from 2024.
  • CNBX Pharmaceuticals Inc. annual Return On Assets for 2024 was -420%, a 37% increase from 2023.
  • CNBX Pharmaceuticals Inc. annual Return On Assets for 2023 was -665%, a 125% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

CNBX Pharmaceuticals Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -1591% -851% -115% 01 Sep 2025 30 Nov 2025
Q3 2025 -1142% -722% -172% 01 Jun 2025 31 Aug 2025
Q2 2025 -730% -303% -71% 01 Mar 2025 31 May 2025
Q1 2025 -641% -353% -123% 01 Dec 2024 28 Feb 2025
Q4 2024 -741% -38% -5.4% 01 Sep 2024 30 Nov 2024
Q3 2024 -420% +245% +37% 01 Jun 2024 31 Aug 2024
Q2 2024 -428% +141% +25% 01 Mar 2024 31 May 2024
Q1 2024 -288% +294% +51% 01 Dec 2023 29 Feb 2024
Q4 2023 -703% -390% -124% 01 Sep 2023 30 Nov 2023
Q3 2023 -665% -369% -125% 01 Jun 2023 31 Aug 2023
Q2 2023 -568% -353% -164% 01 Mar 2023 31 May 2023
Q1 2023 -582% -402% -223% 01 Dec 2022 28 Feb 2023
Q4 2022 -313% -202% -183% 01 Sep 2022 30 Nov 2022
Q3 2022 -296% -201% -214% 01 Jun 2022 31 Aug 2022
Q2 2022 -215% -113% -110% 01 Mar 2022 31 May 2022
Q1 2022 -180% -107% -145% 01 Dec 2021 28 Feb 2022
Q4 2021 -111% -19% -21% 01 Sep 2021 30 Nov 2021
Q3 2021 -94% +74% +44% 01 Jun 2021 31 Aug 2021
Q2 2021 -102% +3.4% +3.3% 01 Mar 2021 31 May 2021
Q1 2021 -73% -2.8% -3.9% 01 Dec 2020 28 Feb 2021
Q4 2020 -92% -69% -308% 01 Sep 2020 30 Nov 2020
Q3 2020 -168% -175% -2427% 01 Jun 2020 31 Aug 2020
Q2 2020 -106% -120% -848% 01 Mar 2020 31 May 2020
Q1 2020 -71% -88% -511% 01 Dec 2019 29 Feb 2020
Q4 2019 -22% +57% +72% 01 Sep 2019 30 Nov 2019
Q3 2019 7.2% +122% 01 Jun 2019 31 Aug 2019
Q2 2019 14% +136% 01 Mar 2019 31 May 2019
Q1 2019 17% +119% 01 Dec 2018 28 Feb 2019
Q4 2018 -80% +6.8% +7.8% 01 Sep 2018 30 Nov 2018
Q3 2018 -115% -18% -19% 01 Jun 2018 31 Aug 2018
Q2 2018 -122% -39% -46% 01 Mar 2018 31 May 2018
Q1 2018 -101% +177% +64% 01 Dec 2017 28 Feb 2018
Q4 2017 -86% +244% +74% 01 Sep 2017 30 Nov 2017
Q3 2017 -97% +454% +82% 01 Jun 2017 31 Aug 2017
Q2 2017 -83% +676% +89% 01 Mar 2017 31 May 2017
Q1 2017 -279% +1075% +79% 01 Dec 2016 28 Feb 2017
Q4 2016 -330% +1099% +77% 01 Sep 2016 30 Nov 2016
Q3 2016 -551% +547% +50% 01 Jun 2016 31 Aug 2016
Q2 2016 -760% -45% -6.2% 01 Mar 2016 31 May 2016
Q1 2016 -1354% -709% -110% 01 Dec 2015 29 Feb 2016
Q4 2015 -1429% -675% -90% 01 Sep 2015 30 Nov 2015
Q3 2015 -1098% -361% -49% 01 Jun 2015 31 Aug 2015
Q2 2015 -715% -208% -41% 01 Mar 2015 31 May 2015
Q1 2015 -645% -332% -106% 01 Dec 2014 28 Feb 2015
Q4 2014 -754% 01 Sep 2014 30 Nov 2014
Q3 2014 -736% 01 Jun 2014 31 Aug 2014
Q2 2014 -507% 01 Mar 2014 31 May 2014
Q1 2014 -312% 01 Dec 2013 28 Feb 2014

CNBX Pharmaceuticals Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2025 -1142% -722% -172% 01 Sep 2024 31 Aug 2025
2024 -420% +245% +37% 01 Sep 2023 31 Aug 2024
2023 -665% -369% -125% 01 Sep 2022 31 Aug 2023
2022 -296% -201% -214% 01 Sep 2021 31 Aug 2022
2021 -94% +74% +44% 01 Sep 2020 31 Aug 2021
2020 -168% -175% -2427% 01 Sep 2019 31 Aug 2020
2019 7.2% +122% 01 Sep 2018 31 Aug 2019
2018 -115% -18% -19% 01 Sep 2017 31 Aug 2018
2017 -97% +454% +82% 01 Sep 2016 31 Aug 2017
2016 -551% +547% +50% 01 Sep 2015 31 Aug 2016
2015 -1098% -361% -49% 01 Sep 2014 31 Aug 2015
2014 -736% 01 Sep 2013 31 Aug 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.